Newsletter May 2017

*|MC:SUBJECT|*
Toxys Newsletter May 2017
View this email in your browser
Toxys logo
Toxys launches large international validation study for ToxTracker        

Leiden,  1 May 2017 - Together with a consortium of leading experts in the field of genotoxicity, Toxys has started a large inter-laboratory validation study for their ToxTracker assay. With this study, Toxys aims to demonstrate the transferability, intra- and inter-laboratory reproducibility as well as the predictive capacity of the assay. In 2015, a preliminary inter-laboratory validation study already indicated an excellent transferability and reproducibility. Now, in a large international validation study, together with seven expert laboratories, Toxys is determined to confirm the outstanding performance and added value of the ToxTracker assay. The validation study is initiated in parallel to the recent initiatives towards the European Center for Validation of Alternative Methods (ECVAM) and the Organisation for Economic Cooperation and Development (OECD) and should contribute to regulatory acceptance of the ToxTracker assay.


















Read more

Novel publications

Publication:
Good cell culture practices & in vitro toxicology by Eskes et al.,  2017


Poster presentations SOT 2017: 
Use of Multiparametric Mode of Action approached for Genetic Toxicity Assesment: ToxTracker reporter cell lines versus gene array analysis - together with Procter & Gamble

Validation of ToxTracker reporter assay for genetic toxicology assessment of petroleum products - together with the petrochemical industry (Concawe) 

Mechanism-based genotoxicity screening of nanomaterials using the ToxTracker panel of reporter cell lines - together with Karolinska Institute (Sweden)

Application of the ToxTracker reporter assay in a mode of action approach for genetic toxicology assessment  
 

News in short
ToxTracker presented in webinar by Charles River about genotoxicity testing: Avoid Program Set-Backs: Deciphering Positive Responses
link to webinar

Toxys is part of the organising committee for the GTTC Mode of Action workshop at the annual meeting of the  American Genetic Toxicology Association (May 10th 2017)
Click for more information

Business Development position open
To continue growing our business we are looking for a business developer, please read more in this job description

Toxys mentioned as top-10 Biotech in Leiden
In this article by Labiotech.eu Toxys is mentioned as one of the top-10 biotech companies in Leiden.  
Opportunities to get in contact
We will attend and give presentations at several conferences this year. We are more than happy to meet alongside any of these meetings. If you are interested to learn more about our unique assays we could also schedule a TC to take you to a presentation on the assay.

Meetings we will attend: 
- GTTC/GTA 10-12 May 2017
- Joint Belgium, Dutch and UK Environmental Mutagenesis Society meeting 2017 25-28 June 2017
- Eurotox 10-13 September 2017
- ICEM 12-16 November 2017

Please contact me if there are any questions: 
Paula van Rossum 
Director Business Development & Sales
p.vanrossum@toxys.com
+31 - 71 - 3322470


 
Learn more about our unique services
LinkedIn
LinkedIn
Twitter
Twitter
Website
Website
Copyright © 2015 Toxys B.V., All rights reserved.
Please visit our website for more information






This email was sent to *|EMAIL|*
why did I get this?    unsubscribe from this list    update subscription preferences
*|LIST:ADDRESSLINE|*

*|REWARDS|*